Growth hormone signaling pathways

Growth Hormone and IGF Research

Volumn 28, Issue , 2016, Pages 11-15

  Carter Su, Christin ^a   Schwartz, Jessica ^a   Argetsinger, Lawrence S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Growth hormone; JAK2; SH2B1; Signal transduction

Indexed keywords

GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; GROWTH HORMONE; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SHC; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAF PROTEIN; RAS PROTEIN; SCAFFOLD PROTEIN; SH2B1 PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; SOMATOMEDIN C; SOS PROTEIN; STAT PROTEIN; UNCLASSIFIED DRUG; GROWTH HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; SH2B1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL MOTILITY; ENZYME PHOSPHORYLATION; GENE; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; INSULIN LIKE GROWTH FACTOR 1 GENE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ACTIN FILAMENT; ANIMAL; CELL MOTION; CHILDHOOD OBESITY; GENETICS; INSULIN RESISTANCE; METABOLISM; PHOSPHORYLATION;

ACTIN CYTOSKELETON; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL MOVEMENT; GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; JANUS KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PEDIATRIC OBESITY; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 84963795503     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2015.09.002     Document Type: Article

References (69)

1. Adamson U. On the diabetogenic effect of growth hormone in man: effects of growth hormone of glucagon and insulin secretion. Eur. J. Clin. Investig. 1981, 11:115-119.
2. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R., Reese C.B., Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Ba. Curr. Biol. 1997, 7:261-269.
3. Argetsinger L.S., Campbell G.S., Yang X., Witthuhn B.A., Silvennoinen O., Ihle J.N., Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 1993, 74:237-244.
4. Argetsinger L.S., Hsu G.W., Myers M.G., Billestrup N., White M.F., Carter-Su C. Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 1995, 270:14685-14692.
5. Argetsinger L.S., Norstedt G., Billestrup N., White M.F., Carter-Su C. Growth hormone, interferon-γ, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J. Biol. Chem. 1996, 271:29415-29421.
6. Bazan J.F. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor B-chain. Biochem. Biophys. Res. Commun. 1989, 164:788-795.
7. Behrens L.H., Barr D.P. Hyperpituitarism beginning in infancy: the alton giant. Endocrinology 1932, 16:120-128.
8. Bochukova E.G., Huang N., Keogh J., Henning E., Purmann C., Blaszczyk K., Saeed S., Hamilton-Shield J., Clayton-Smith J., O'Rahilly S., Hurles M.E., Farooqi I.S. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 2010, 463:666-670.
9. Campbell G.S., Meyer D.J., Raz R., Levy D.E., Schwartz J., Carter-Su C. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. J. Biol. Chem. 1995, 270:3974-3979.
10. Carter-Su C., Rozsa F.A., Wang X., Stubbart J.R. Rapid and transitory stimulation of 3-O-methylglucose transport by growth hormone. Am. J. Physiol. 1988, 255:E723-E729.
11. Carter-Su C., Schwartz J., Kikuchi G. Identification of a high affinity growth hormone receptor in rat adipocyte membranes. J. Biol. Chem. 1984, 259:1099-1104.
12. Carter-Su C., Stubbart J.R., Wang X., Stred S.E., Argetsinger L.S., Shafer J.A. Phosphorylation of highly purified growth hormone receptors by a growth hormone receptor-associated tyrosine kinase. J. Biol. Chem. 1989, 264:18654-18661.
13. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 1994, 14:4902-4911.
14. Cheek D.B., Hill D.E., Sawyer W.H. Effect of growth hormone on cell and somatic growth. Handbook of Physiology 1974, vol. 4, part 2. American Physiological Society, Washington, DC, sect. 7.
15. Chudasama K.K., Winnay J., Johansson S., Claudi T., Konig R., Haldorsen I., Johansson B., Woo J.R., Aarskog D., Sagen J.V., Kahn C.R., Molven A., Njolstad P.R. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. Am. J. Hum. Genet. 2013, 93:150-157.
16. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 1993, 14:20-39.
17. Cui T.X., Kwok R., Schwartz J. Cooperative regulation of endogenous cAMP-response element binding protein and CCAAT/enhancer-binding protein beta in GH-stimulated c-fos expression. J. Endocrinol. Investig. 2008, 196:89-100.
18. Diakonova M., Gunter D.R., Herrington J., Carter-Su C. SH2-Bβ is a Rac-binding protein that regulates cell motility. J. Biol. Chem. 2002, 277:10669-10677.
19. Doche M.D., Bochukova E.G., Su H.W., Pearce L., Keogh J.M., Henning E., Cline J.M., Dale A., Cheetham T., Barroso I., Argetsinger L.S., O'Rahilly S.O., Rui L., Carter-Su C., Farooqi I.S. SH2B1 mutations are associated with maladaptive behavior and obesity. J. Clin. Invest. 2012, 122:4732-4736.
20. Eshet R., Laron Z., Pertzelan A., Arnon R., Dintzman M. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr. J. Med. Sci. 1984, 20:8-11.
21. Fu X.-Y., Schindler C., Improta T., Aebersold R., Darnell J.E. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:7840-7843.
22. Geiger B., Spatz J.P., Bershadsky A.D. Environmental sensing through focal adhesions. Nat. Rev. Mol. Cell Biol. 2009, 10:21-33.
23. Ghoreschi K., Laurence A., O'Shea J.J. Janus kinases in immune cell signaling. Immunol. Rev. 2009, 228:273-287.
24. Herrington J., Diakonova M., Rui L., Gunter D.R., Carter-Su C. SH2-B is required for growth hormone-induced actin reorganization. J. Biol. Chem. 2000, 275:13126-13133.
25. Herrington J., Rui L., Luo G., Yu-Lee L.-y., Carter-Su C. A functional DNA-binding domain is required for growth hormone-induced nuclear localization of Stat5B. J. Biol. Chem. 1999, 274:5138-5145.
26. Hodge C., Liao J., Stofega M., Guan K., Carter-Su C., Schwartz J. Growth hormone stimulates phosphorylation and activation of Elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J. Biol. Chem. 1998, 273:31327-31336.
27. Hwa V., Little B., Adiyaman P., Kofoed E.M., Pratt K.L., Ocal G., Berberoglu M., Rosenfeld R.G. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J. Clin. Endocrinol. Metab. 2005, 90:4260-4266.
28. Kessler D.S., Veals S.A., Fu X.-Y., Levy D.E. Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev. 1990, 4:1753-1765.
29. Kurzer J., Carter-Su C., D.E.L. Growth hormone induced activation and regulation of Jak2 and Stat proteins. Signal Transducers and Activators of Transcription (STATs) 2003, 177-190. Kluwer Academic Press, Dordrecht, Netherlands. P.B. Sehgal, T. Hirano (Eds.).
30. Kurzer J.H., Argetsinger L.S., Zhou Y.-J., Kouadio J.-L., O'Shea J.J., Carter-Su C. Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-Bβ. Mol. Cell. Biol. 2004, 24:4557-4570.
31. Lanning N.J., Carter-Su C. Recent advances in growth hormone signaling. Rev. Endocr. Metab. Disord. 2006, 7:225-235.
32. Lanning N.J., Su H.W., Argetsinger L.S., Carter-Su C. Identification of SH2B1β as a focal adhesion protein that regulates focal adhesion size and number. J. Cell Sci. 2011, 124:3095-3105.
33. Leung D.W., Spencer S.A., Cachianes G., Hammonds R.G., Collins C., Henzel W.J., Barnard R., Waters M.J., Wood W.I. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987, 330:537-543.
34. Liao J., Hodge C., Meyer D., Ho P.S., Rosenspire K., Schwartz J. Growth hormone regulates ternary complex factors and serum response factor associated with the c-fos serum response element. J. Biol. Chem. 1997, 272:25951-25958.
35. Maures T.J., Kurzer J.H., Carter-Su C. SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other. Trends Endocrinol. Metab. 2007, 18:38-45.
36. Meyer D.J., Campbell G.S., Cochran B.H., Argetsinger L.S., Larner A.C., Finbloom D.S., Carter-Su C., Schwartz J. Growth hormone induces a DNA binding factor related to the interferon-stimulated 91kD transcription factor. J. Biol. Chem. 1994, 269:4701-4704.
37. Meyer D.J., Stephenson E.W., Johnson L., Cochran B.H., Schwartz J. The serum response element can mediate the induction of c-fos by growth hormone. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:6721-6725.
38. Mul D., Wu S., de Paus R.A., Oostdijk W., Lankester A.C., Duyvenvoorde H.A., Ruivenkamp C.A., Losekoot M., Tol M.J., De Luca F., van de Vosse E., Wit J.M. A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-kappaB activation. Eur. J. Endocrinol. 2012, 166:743-752.
39. O'Brien K.B., Argetsinger L.S., Diakonova M., Carter-Su C. YXXL motifs in SH2-Bb are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling. J. Biol. Chem. 2003, 278:11970-11978.
40. O'Brien K.B., O'Shea J.J., Carter-Su C. SH2-B family members differentially regulate JAK family tyrosine kinases. J. Biol. Chem. 2002, 277:8673-8681.
41. Osborne M.A., Dalton S., Kochan J.P. The yeast tribrid system - genetic detection of trans-phosphorylated ITAM-SH2-interactions. Biotechnology 1995, 13:1474-1478.
42. Pearce L.R., Joe R., Doche M.D., Su H.W., Keogh J.M., Henning E., Argetsinger L.S., Bochukova E.G., Cline J.M., Garg S., Saeed S., Shoelson S., O'Rahilly S., Barroso I., Rui L., Farooqi I.S., Carter-Su C. Functional characterisation of obesity-associated variants involving the alpha and beta isoforms of human SH2B1. Endocrinology 2014, 9:3219-3226.
43. Piwien-Pilipuk G., Huo J.S., Schwartz J. Growth hormone signal transduction. J. Pediatr. Endocrinol. Metab. 2002, 15:771-786.
44. Piwien-Pilipuk G., Van Mater D., Ross S.E., MacDougald O.A., Schwartz J. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein b by modulating Akt and glycogen synthase kinase-3. J. Biol. Chem. 2001, 276:19664-19671.
45. Ren D., Li M., Duan C., Rui L. Identification of SH2-B as a key regulator of leptin sensitivity, energy balance and body weight in mice. Cell Metab. 2005, 2:95-104.
46. Rui L., Carter-Su C. Identification of SH2-Bβ as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7172-7177.
47. Rui L., Mathews L.S., Hotta K., Gustafson T.A., Carter-Su C. Identification of SH2-Bβ as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol. Cell. Biol. 1997, 17:6633-6644.
48. Shuai K., Schindler C., Prezioso V.R., Darnell J.E. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 1992, 258:1808-1812.
49. Shuai K., Stark G.R., Kerr I.M., Darnell J.E. A single phosphotyrosine residue of Stat1 required for gene activation by interferon-γ. Science 1993, 261:1744-1746.
50. Smit L.S., Meyer D.J., Billestrup N., Norstedt G., Schwartz J., Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol. Endocrinol. 1996, 10:519-533.
51. Smit L.S., VanderKuur J.A., Stimage A., Han Y., Luo G., Yu-lee L., Schwartz J., Carter-Su C. Growth hormone-induced tyrosyl phosphorylation and DNA binding activity of Stat5A and Stat5B. Endocrinology 1997, 138:3426-3434.
52. Sotiropoulos A., Moutoussamy S., Renaudie F., Clauss M., Kayser C., Gouilleux F., Kelly P.A., Finidori J. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol. Endocrinol. 1996, 10:998-1009.
53. Stofega M.R., Argetsinger L.S., Wang H., Ullrich A., Carter-Su C. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein a. J. Biol. Chem. 2000, 275:28222-28229.
54. Stofega M.R., Wang H., Ullrich A., Carter-Su C. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association. J. Biol. Chem. 1998, 273:7112-7117.
55. Su H.W., Lanning N.J., Morris D.L., Argetsinger L.S., Lumeng C.N., Carter-Su C. Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility. J. Cell Sci. 2013, 126:1733-1743.
56. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., White M.F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991, 352:73-77.
57. Tamburrino F., Gibertoni D., Rossi C., Scarano E., Perri A., Montanari F., Fantini M.P., Pession A., Tartaglia M., Mazzanti L. Response to long-term growth hormone therapy in patients affected by RAsopathies and growth hormone deficiency: patterns of growth, puberty and final height data. Am. J. Med. Genet. A 2015.
58. Taub D.D., Tsarfaty G., Lloyd A.R., Durum S.K., Longo D.L., Murphy W.J. Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J. Clin. Invest. 1994, 94:293-300.
59. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., Waxman D.J., Davey H.W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:7239-7244.
60. VanderKuur J., Allevato G., Billestrup N., Norstedt G., Carter-Su C. Growth hormone-promoted tyrosyl phosphorylation of Shc proteins and Shc association with Grb2. J. Biol. Chem. 1995, 270:7587-7593.
61. VanderKuur J.A., Butch E.R., Waters S.B., Pessin J.E., Guan K.-L., Carter-Su C. Signalling molecules involved in coupling growth hormone receptor to MAP kinase activation. Endocrinology 1997, 138:4301-4307.
62. Velazquez L., Fellous M., Stark G.R., Pellegrini S. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 1992, 70:313-322.
63. Wang X., Uhler M.D., Billestrup N., Norstedt G., Talamantes F., Nielsen J.H., Carter-Su C. Evidence for association of the cloned liver growth hormone receptor with a tyrosine kinase. J. Biol. Chem. 1992, 267:17390-17396.
64. Watling D., Guschin D., Muller M., Silvennoinen O., Witthuhn B.A., Quelle F.W., Rogers N.C., Schindler C., Stark G.R., Ihle J.N., Kerr I.M. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 1993, 366:166-170.
65. Waxman D.J., O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol. Endocrinol. 2006, 20:2613-2629.
66. Wiedermann C.J., Reinisch N., Braunsteiner H. Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. Blood 1993, 82:954-960.
67. Wilks A.F., Harpur A.G., Kurban R.R., Ralph S.J., Zurcher G., Ziemiecki A. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol. Cell. Biol. 1991, 11:2057-2065.
68. Witthuhn B.A., Quelle F.W., Silvennoinen O., Yi T., Tang B., Miura O., Ihle J.N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993, 74:227-236.
69. Zehorai E., Yao Z., Plotnikov A., Seger R. The subcellular localization of MEK and ERK-a novel nuclear translocation signal (NTS) paves a way to the nucleus. Mol. Cell. Endocrinol. 2010, 314:213-220.